PRODUCTS
Product Portfolio
Helicon has built a portfolio of advanced high end biomedical products targeting the following market segments:
- Blood Plasma Substitute
Helicon has exclusive rights to this gelatine based product Volplex® for China and South Korea which will bring significant benefits in the treatment of post surgical or post traumatic hypovoleamia.
- Burn, scar and skin defect treatment
Helicon has exclusive rights in China and Hong Kong to ReCell®, a breakthrough technology offering clinicians an opportunity to use advanced tissue engineering techniques for the treatment of burns, scalds and the reconstruction of scars and other skin defects.
- Wound and Surgical Site Infections Management
Helicon has exclusive rights to Collatamp® G for the China market. The collagen based infection management device, which contains the broad spectrum antibiotic Gentamycin, has proven effectiveness in minimising post surgical site infections whilst reducing the risk of toxicity and the associated systemic side effects.
Helicon has exclusive rights for China and a number of Asian markets to MedWrap’s Island Wound Dressing with Microban®, a patented wound management technology. The incorporation of an active antibacterial into this dressing provides significant enhancement in healing and antibacterial protection when compared to traditional gauze dressings.
These products are currently at various stages of evaluation by Regulatory Authorities.
HOME
PRODUCTS